Intech Biopharm Corporation
6461
Rank in Stocks
#20303
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Share Price
$0.7910717
Last synced: 2026-11-10
Market Cap
$87.27M
Change (1 day)
-0.76%
Change (1 year)
59.21%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Intech Biopharm Corporation (6461)
Category
Healthcare
Operating Margin for Intech Biopharm Corporation (6461)
Operating Margin as of November 2026 TTM: -957.88%
According to Intech Biopharm Corporation's latest financial reports, its current operating margin (TTM) is -957.88%. At the end of 2025 the company had an operating margin of -338.99%.
Operating Margin history for Intech Biopharm Corporation from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -957.88% | 182.57% |
| 2025 | -338.99% | -62.14% |
| 2024 | -895.26% | -27.79% |
| 2023 | -1,239.87% | -3.82% |
| 2022 | -1,289.11% | 77.68% |
| 2021 | -725.51% | -34.44% |
| 2020 | -1,106.60% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.04% |
US
|
|
| -149.01% | -99.84% |
US
|
|
| 25.57% | -100.03% |
AU
|
|
| 31.23% | -100.03% |
BE
|
|
| 29.35% | -100.03% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Intech Biopharm Corporation's operating margin
What is Intech Biopharm Corporation's operating margin?
Intech Biopharm Corporation's operating margin is -957.88%, as of Nov 2026.
What was Intech Biopharm Corporation's operating margin in 2025?
In 2025, Intech Biopharm Corporation's operating margin was -338.99%, compared with -895.26% in 2024.
How has Intech Biopharm Corporation's operating margin changed since 2020?
From 2020 to 2025, Intech Biopharm Corporation's operating margin was highest in 2025 (-338.99%) and lowest in 2022 (-1,289.11%).
How does Intech Biopharm Corporation's operating margin compare with similar companies?
Intech Biopharm Corporation's operating margin (-957.88%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.